Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trulieve CannabisSTU:F09 61 Market Cap is €1,676.9 Mil as of Aug. 20, 2026. GuruFocus rates STU:F09 with a GF Score™ of 61/100 and a GF Value™ of €5.17 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 1,021 Drug Manufacturers companies, Trulieve Cannabis ranks better than 83.55% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Trulieve Cannabis's share price for the quarter that ended in Jun. 2026 was €8.5. Trulieve Cannabis's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 192.4 Mil. Therefore, Trulieve Cannabis's market cap for the quarter that ended in Jun. 2026 was €1,635.3 Mil.
Trulieve Cannabis's quarterly market cap
declined
from Dec. 2025 (€1,285.6 Mil) to Mar. 2026 (€919.2 Mil) but then
increased
from Mar. 2026 (€919.2 Mil) to Jun. 2026 (€1,635.3 Mil).
Trulieve Cannabis's annual market cap
declined
from Dec. 2023 (€862.6 Mil) to Dec. 2024 (€858.4 Mil) but then
increased
from Dec. 2024 (€858.4 Mil) to Dec. 2025 (€1,285.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Trulieve Cannabis's Enterprise Value for Today is €1,893.1 Mil.
Trulieve Cannabis (STU:F09) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Trulieve Cannabis Market Cap Related Terms
Trulieve Cannabis Market Cap Historical Data
* Premium members only.
The historical data trend for Trulieve Cannabis's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:F09 vs ANIP, XERS, HROW: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trulieve Cannabis Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Market Cap distribution charts can be found below:
* The bar in red indicates where Trulieve Cannabis's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Trulieve Cannabis's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trulieve Cannabis (STU:F09) has a Market Cap of €1,676.9 Mil as of Aug. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Trulieve Cannabis and its competitors. According to the industry distribution chart, Trulieve Cannabis ranks #168 out of 1021 companies in the Drug Manufacturers industry, placing it in the top 16.5%.
Is Trulieve Cannabis' Market Cap too high?
Trulieve Cannabis' current Market Cap is €1,676.9 Mil. Based on the distribution chart, Trulieve Cannabis ranks #168 out of 1021 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Trulieve Cannabis has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Trulieve Cannabis' Market Cap compare to ANIP and XERS?
According to the Drug Manufacturers industry distribution chart, Trulieve Cannabis ranks #168 out of 1021 companies for Market Cap. This places Trulieve Cannabis in the top 17% of its industry — outperforming the majority of peers. The industry median Market Cap is 228.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 228.50, based on 1,021 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Trulieve Cannabis and its competitors. For the Drug Manufacturers industry, the median Market Cap is 228.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trulieve Cannabis's current Market Cap is €1,676.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trulieve Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Trulieve Cannabis (STU:F09) is currently considered Significantly Overvalued. The stock's GF Value™ is €5.17, compared to a current price of €7.83 — trading 51.5% above its estimated fair value. The current Market Cap is €1,676.9 Mil. Trulieve Cannabis' overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Trulieve Cannabis (STU:F09), the current Market Cap is €1,676.9 Mil as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trulieve Cannabis (STU:F09) Overvalued in 2026?
Based on GuruFocus' analysis, Trulieve Cannabis stock appears to be overvalued.
The current stock price of €7.83 is trading 51.5% above its estimated GF Value™ of €5.17.
GuruFocus considers Trulieve Cannabis to be Significantly Overvalued.
Key valuation signals for STU:F09:
Market Cap: €1,676.9 Mil
GF Value™: €5.17 vs. price of €7.83 (51.5% above fair value)
No single metric tells the full story. See the STU:F09 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.
61GF Score
Get the complete analysis for STU:F09
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:F09 has been successfully added to your 
